Auteurs
Checkpoint
Ncbi
Racine
Checkpoint
Ncbi
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (Ncbi)

Index « Auteurs » - entrée « Takao Koike »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Takao Kodera < Takao Koike < Takao Masaki  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 9.
Ident.Authors (with country if any)Title
000353 (2011) Takao Koike [Japon] ; Masayoshi Harigai [Japon] ; Shigeko Inokuma [Japon] ; Naoki Ishiguro [Japon] ; Junnosuke Ryu [Japon] ; Tsutomu Takeuchi [Japon] ; Yoshiya Tanaka [Japon] ; Hisashi Yamanaka [Japon] ; Koichi Fujii [Japon] ; Takunari Yoshinaga [Japon] ; Bruce Freundlich [États-Unis] ; Michio Suzukawa [Japon]Safety and effectiveness responses to etanercept for rheumatoid arthritis in Japan: a sub-analysis of a post-marketing surveillance study focusing on the duration of rheumatoid arthritis
000404 (2011) Jun Fukae [Japon] ; Masato Isobe ; Akemi Kitano ; Mihoko Henmi ; Fumihiko Sakamoto ; Akihiro Narita ; Takeya Ito ; Akio Mitsuzaki ; Masato Shimizu ; Kazuhide Tanimura ; Megumi Matsuhashi ; Tamotsu Kamishima ; Tatsuya Atsumi ; Takao KoikeRadiographic prognosis of finger joint damage predicted by early alteration in synovial vascularity in patients with rheumatoid arthritis: Potential utility of power doppler sonography in clinical practice.
000437 (2011) Takao Koike [Japon] ; Masayoshi Harigai ; Shigeko Inokuma ; Naoki Ishiguro ; Junnosuke Ryu ; Tsutomu Takeuchi ; Syuji Takei ; Yoshiya Tanaka ; Kyoko Ito ; Hisashi YamanakaPostmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: interim analysis of 3881 patients.
000577 (2012) Ryoko Sakai [Japon] ; Michi Tanaka ; Toshihiro Nanki ; Kaori Watanabe ; Hayato Yamazaki ; Ryuji Koike ; Hayato Nagasawa ; Koichi Amano ; Kazuyoshi Saito ; Yoshiya Tanaka ; Satoshi Ito ; Takayuki Sumida ; Atsushi Ihata ; Yoshiaki Ishigatsubo ; Tatsuya Atsumi ; Takao Koike ; Atsuo Nakajima ; Naoto Tamura ; Takao Fujii ; Hiroaki Dobashi ; Shigeto Tohma ; Takahiko Sugihara ; Yukitaka Ueki ; Akira Hashiramoto ; Atsushi Kawakami ; Noboru Hagino ; Nobuyuki Miyasaka ; Masayoshi HarigaiDrug retention rates and relevant risk factors for drug discontinuation due to adverse events in rheumatoid arthritis patients receiving anticytokine therapy with different target molecules.
000585 (2013) Akito Takamura [Japon] ; Shintaro Hirata ; Hayato Nagasawa ; Hideto Kameda ; Yohei Seto ; Tatsuya Atsumi ; Makoto Dohi ; Takao Koike ; Nobuyuki Miyasaka ; Masayoshi HarigaiA retrospective study of serum KL-6 levels during treatment with biological disease-modifying antirheumatic drugs in rheumatoid arthritis patients: a report from the Ad Hoc Committee for Safety of Biological DMARDs of the Japan College of Rheumatology.
000694 (2013) Jun Fukae [Japon] ; Masato Isobe ; Akemi Kitano ; Mihoko Henmi ; Fumihiko Sakamoto ; Akihiro Narita ; Takeya Ito ; Akio Mitsuzaki ; Masato Shimizu ; Kazuhide Tanimura ; Megumi Matsuhashi ; Tamotsu Kamishima ; Tatsuya Atsumi ; Takao KoikePositive synovial vascularity in patients with low disease activity indicates smouldering inflammation leading to joint damage in rheumatoid arthritis: time-integrated joint inflammation estimated by synovial vascularity in each finger joint.
000938 (2014) Takao Koike [Japon] ; Masayoshi Harigai ; Shigeko Inokuma ; Naoki Ishiguro ; Junnosuke Ryu ; Tsutomu Takeuchi ; Syuji Takei ; Yoshiya Tanaka ; Yoko Sano ; Hitomi Yaguramaki ; Hisashi YamanakaEffectiveness and safety of tocilizumab: postmarketing surveillance of 7901 patients with rheumatoid arthritis in Japan.
001074 (2016) Masayoshi Harigai ; Toshihiro Nanki ; Ryuji Koike ; Michi Tanaka ; Kaori Watanabe-Imai ; Yukiko Komano ; Ryoko Sakai ; Hayato Yamazaki ; Takao Koike [Japon] ; Nobuyuki Miyasaka [Japon]Risk for malignancy in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs compared to the general population: A nationwide cohort study in Japan.
001C51 (2019) Toshiyuki Watanabe [Japon] ; Jun Fukae [Japon] ; Shinji Fukaya [Japon] ; Norifumi Sawamukai [Japon] ; Masato Isobe [Japon] ; Megumi Matsuhashi [Japon] ; Masato Shimizu [Japon] ; Kazumasa Akikawa [Japon] ; Kazuhide Tanimura [Japon] ; Tatsuya Atsumi [Japon] ; Takao Koike [Japon]Incidence and risk factors for reactivation from resolved hepatitis B virus in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i -k "Takao Koike" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i  \
                -Sk "Takao Koike" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Takao Koike
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021